In June 2024, Abbott received a pair of clearances for its Libre Rio and Lingo CGM systems, both the company’s first to become available without a prescription. Based on its FreeStyle Libre ...
The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...